BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16525490)

  • 41. Long-term follow-up of patients with chronic myeloid leukemia having received autologous stem cell transplantation.
    Hackanson B; Waller CF
    Ann Hematol; 2011 Apr; 90(4):395-9. PubMed ID: 20922524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolated central nervous system blast crisis in chronic myeloid leukemia.
    Rajappa S; Uppin SG; Raghunadharao D; Rao IS; Surath A
    Hematol Oncol; 2004 Dec; 22(4):179-81. PubMed ID: 15995975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors predicting molecular and cytogenetic response in chronic myeloid leukemia patients treated with imatinib.
    Roche-Lestienne C; Darré S; Laï JL; Facon T; Guilhot J; Preudhomme C
    Haematologica; 2005 Jan; 90(1):131-3. PubMed ID: 15642682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase.
    Luo Y; Lai XY; Tan YM; Shi JM; Zhao YM; Han XY; Zheng GF; Zhu XL; Sun J; Zheng YL; Wu GQ; He JS; Chen SY; Jin AY; Xie WZ; Ye XJ; Cai Z; Lin MF; Huang H
    Leukemia; 2009 Jun; 23(6):1171-4. PubMed ID: 19194468
    [No Abstract]   [Full Text] [Related]  

  • 45. Recurrence of lymphoid blast crisis over 20 years after successful sibling allo-SCT for CML: short lived complete cytogenetic response to imatinib.
    Irvine DA; Shepherd JD
    Bone Marrow Transplant; 2009 Aug; 44(4):267-8. PubMed ID: 19234506
    [No Abstract]   [Full Text] [Related]  

  • 46. Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.
    Bacigalupo A
    Leukemia; 2003 Sep; 17(9):1722. PubMed ID: 12970770
    [No Abstract]   [Full Text] [Related]  

  • 47. Imatinib resistance and blast transformation of chronic myeloid leukemia associated with a novel tri-nucleotide insertion mutation of BCR-ABL kinase domain at position K294.
    Nadarajan VS; Ang CH; Syed-Sultan MK; Bee PC
    Ann Hematol; 2012 Jan; 91(1):125-7. PubMed ID: 21442193
    [No Abstract]   [Full Text] [Related]  

  • 48. Successful unrelated allogeneic stem cell transplantation after treatment of lymphoid blast crisis CML with imatinib and imatinib-containing conditioning regimen in a 16-year-old male.
    Koch M; Lang P; Bader P; Kreyenberg H; Schumm M; Scheel-Walter H; Hochhaus A; Niethammer D; Greil J
    Bone Marrow Transplant; 2003 Sep; 32(5):541-2. PubMed ID: 12942103
    [No Abstract]   [Full Text] [Related]  

  • 49. Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation.
    Bogdanić V; Aurer I; Hitrec V; Boban D; Nemet D; Zupancić-Salek S; Labar B
    Haematologica; 1995; 80(4):338-40. PubMed ID: 7590504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests.
    Janssen JJ; van Rijn RS; van der Holt B; Schuurhuis GJ; Vellenga E; Verhoef GE; Ossenkoppele GJ; van den Berg E; Hagemeijer A; Släter R; Nieuwint AW; Cornelissen JJ
    Bone Marrow Transplant; 2000 Jun; 25(11):1147-55. PubMed ID: 10849527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN BLAST CRISIS.
    Sarwar S; Siddiqui N; Zafar W; Fasih S; Basit A; Hameed A
    J Ayub Med Coll Abbottabad; 2015; 27(2):371-4. PubMed ID: 26411119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term follow-up of patients with Philadelphia chromosome-positive chronic myeloid leukemia after stem cell mobilization under imatinib.
    Kim TD; Schwarz M; Kreuzer KA; Kaeda J; Movassaghi K; Grille P; Daniel PT; Dörken B; Le Coutre P
    Leuk Lymphoma; 2011 Mar; 52(3):517-20. PubMed ID: 21133719
    [No Abstract]   [Full Text] [Related]  

  • 54. Extramedullary relapse of chronic myeloid leukemia in blast crisis: more questions than answers.
    Ross DM
    Leuk Lymphoma; 2009 Apr; 50(4):517-8. PubMed ID: 19373644
    [No Abstract]   [Full Text] [Related]  

  • 55. Dasatinib maintenance therapy after allogeneic hematopoietic stem cell transplantation for an isolated central nervous system blast crisis in chronic myelogenous leukemia.
    Nishimoto M; Nakamae H; Koh KR; Kosaka S; Matsumoto K; Morita K; Koh H; Nakane T; Ohsawa M; Hino M
    Acta Haematol; 2013; 130(2):111-4. PubMed ID: 23548721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autografting with non-clonal mobilized hematopoietic progenitor cells in CML.
    Carella AM
    Leukemia; 2000 May; 14(5):954-5. PubMed ID: 10803537
    [No Abstract]   [Full Text] [Related]  

  • 57. Does early stem-cell transplantation have a role in chronic myeloid leukaemia? Against the proposal.
    Rosti G; Baccarani M
    Lancet Oncol; 2005 Sep; 6(9):722-3. PubMed ID: 16161267
    [No Abstract]   [Full Text] [Related]  

  • 58. Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemia.
    Chen Z; Medeiros LJ; Kantajian HM; Zheng L; Gong Z; Patel KP; Xiong H; Wang W; Cortes JE; Hu S
    Blood Cancer J; 2017 Feb; 7(2):e521. PubMed ID: 28157214
    [No Abstract]   [Full Text] [Related]  

  • 59. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
    Meloni G; Capria S; Vignetti M; Mandelli F; Modena V
    Blood; 1997 Jun; 89(12):4659. PubMed ID: 9192793
    [No Abstract]   [Full Text] [Related]  

  • 60. Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor.
    Morton J; Mollee P; Taylor K; Grigg A; Durrant S; Moore D; Rodwell R; Eliadis P; Hutchins C; Williams B; Seeley G; Wright S; Kelly C; Rentoul A; Iland H; Atkinson K; Januszewicz H; Bunce I; Bashford J; Stewart C; Taylor D
    Leuk Res; 1999 Feb; 23(2):177-83. PubMed ID: 10071133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.